The Centers for Medicare & Medicaid Services has wrestled for some time with the issue of reimbursement for angioplasty and stenting of the carotid artery in patients who are not good candidates for carotid artery endarterectomy (CAE), and yesterday's announcement that the agency would essentially hold its ground was not well received. One physician who has been involved in the issue for some time called the decision "an open stinking wound," but other voices say CMS already has plans to yield on coverage for high-risk patients. (Medical Device Daily) Read More
